Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Liver Transplant CGM

NCT: NCT07216508 · ENROLLING_BY_INVITATION

NCT IDNCT07216508
StatusENROLLING_BY_INVITATION
Start Date2025-10-13
Completion2027-12-30
SponsorIcahn School of Medicine at Mount Sinai (OTHER)
First posted
Last updated

Brief Summary

This investigator initiated study aims to describe continuous glucose monitoring (CGM) based glycemic metrics after discharge from liver transplant and assess relationship with glycemic metrics and liver transplant outcomes.

Frequently Asked Questions

What is Liver Transplant CGM?

Liver Transplant CGM is a clinical trial registered under NCT07216508. Current status: ENROLLING_BY_INVITATION.

What is the status of NCT07216508?

The current status of NCT07216508 (Liver Transplant CGM) is: ENROLLING_BY_INVITATION.

When did Liver Transplant CGM start?

Liver Transplant CGM started on 2025-10-13.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.